Westend Capital Management, LLC Charles River Laboratories International, Inc. Transaction History
Westend Capital Management, LLC
- $285 Billion
- Q2 2024
A detailed history of Westend Capital Management, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Westend Capital Management, LLC holds 14 shares of CRL stock, worth $2,834. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14
Previous 14
-0.0%
Holding current value
$2,834
Previous $3.79 Million
24.99%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CRL
# of Institutions
728Shares Held
51.3MCall Options Held
183KPut Options Held
346K-
Vanguard Group Inc Valley Forge, PA6.05MShares$1.22 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY5.17MShares$1.05 Billion0.03% of portfolio
-
State Street Corp Boston, MA2.09MShares$424 Million0.03% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.88MShares$380 Million1.21% of portfolio
-
Clearbridge Investments, LLC New York, NY1.51MShares$306 Million0.34% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $10.3B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...